U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 1 to 20 of 29

Tests names and labsConditionsGenes, analytes, and microbesMethods

F13A1 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel

PreventionGenetics, part of Exact Sciences
United States
346160
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Factor XIII (13) Gene Sequencing (F13A1 and F13B) (2 Day STAT TAT)

Machaon Diagnostics
United States
22
  • C Sequence analysis of the entire coding region

Factor XIIIA deficiency, 613225, Autosomal recessive (Congenital factor XIII deficiency) (F13A1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Fibrinolytic Disorder Panel

Versiti Diagnostic Laboratories Versiti, Inc
United States
39
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Congenital Factor XIII deficiency via the F13A1 Gene

PreventionGenetics, part of Exact Sciences
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Bleeding Disorders Panel

PreventionGenetics, part of Exact Sciences
United States
7879
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

F13A1 & F13B gene analysis

Molecular Haemostasis & Thrombosis Viapath - Guy's and St. Thomas' NHS Foundation Trust
United Kingdom
22
  • C Sequence analysis of the entire coding region

Coagulation Factor Deficiency Panel

PreventionGenetics, part of Exact Sciences
United States
2120
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Clotting factor deficiency panel. 16-gene NGS panel.

Genologica Medica
Spain
2916
  • C Sequence analysis of the entire coding region

Bleeding disorder / coagulopathy panel. NGS panel of 62 genes.

Genologica Medica
Spain
9662
  • C Sequence analysis of the entire coding region

F13 V34L poymorphism analysis

Duzen Laboratories Duzen BBAGUAS
Turkey
11
  • T Targeted variant analysis

Factor XIIIA deficiency

Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders
Germany
11
  • C Sequence analysis of the entire coding region

Factor XIII mutation analysis

Genetiks Genetic Diagnosis Center Genetic Diseases Evaluation Center
Turkey
11
  • C Sequence analysis of the entire coding region

Comprehensive Bleeding Disorder Panel

Versiti Diagnostic Laboratories Versiti, Inc
United States
8050
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

F13A1 (Factor XIII-A) - Genetic Analysis

Versiti Diagnostic Laboratories Versiti, Inc
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Factor XIII Genetic Analysis

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
22
  • C Sequence analysis of the entire coding region

Coagulation Disorder Panel

Versiti Diagnostic Laboratories Versiti, Inc
United States
2520
  • D Deletion/duplication analysis
  • S Mutation scanning of the entire coding region

Thrombosis Disorder NGS Panel

Fulgent Genetics
United States
4618
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Primary Immunodeficiency NGS Panel

Fulgent Genetics
United States
1048472
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 29

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.